The purpose of this study is to determine the safety of three doses of topically applied danazol compared to placebo in subjects with pain associated with fibrocystic breast disease and to determine the appropriate clinical dose for future studies.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
60
Subject reported breast pain as measured using a visual analog scale on the subject daily diary
Time frame: 2 cycles pretreatment plus 4 cycles on treatment
Physician assessment of breast nodularity at each treatment cycle visit
Time frame: 2 cycles pretreatment plus 4 cycles on treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Women's Health Research
Phoenix, Arizona, United States
Advanced Clinical Therapeutics, LLC
Tucson, Arizona, United States
Impact Clinical Trials
Beverly Hills, California, United States
Women's Health Care at Frost Street
San Diego, California, United States
Horizons Clinical Research Center, LLC
Denver, Colorado, United States
James A Simon, M.D., PC
Washington D.C., District of Columbia, United States
Visions Clinical Research
Boynton Beach, Florida, United States
Southeastern Integrated Medical, LLC
Gainsville, Florida, United States
Palm Beach Research Center
West Palm Beach, Florida, United States
Atlanta North Gynecology, PC
Roswell, Georgia, United States
...and 20 more locations